We know there is significant frustration in the US regarding the cost of healthcare – including prescription medicines. We take this very seriously, as evidenced by our pricing track record. In fact, the launch price of our six most recently introduced new medicines were priced similarly or less than the market leader. This illustrates our commitment to appropriately balance reward for our innovation and ensure broadest patient access.
In 2016, Sanofi has risen 2 positions in the Access To Medicine (ATM) Index, from 8th to 6th rank. The ATM Index analyses the top 20 research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries.
Sanofi’s performance is well recognized this year in the two main areas, which represent 45% of the overall score and are major enablers of access:
More than 170 entrepreneurs from different districts of the Arequipa region of Peru successfully completed the DreamBuilder program in April 2016, which is funded by Freeport-McMoRan Inc., Sociedad Minera Cerro Verde and the Thunderbird School of Global Management.
Former New York City mayor, media mogul and erstwhile presidential contender Michael Bloomberg recently got a new gig: chair of the Financial Stability Board’s (FSB) task force on climate-related financial disclosure.
May 19, 2015 /3BL Media/ - The Thunderbird School of Global Management will launch an English-language version of the Freeport-McMoRan DreamBuilder program.
Freeport-McMoRan’s DreamBuilder program is designed for women entrepreneurs who want to start or grow a small business. The online learning program is available throughout the United States in association with the Small Business Administration.